Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025)
Siga Technologies' (SIGA) quarterly Other Non-Current Liabilities came in at $2.7 million in Q4 2025, down 17.1% YoY from $3.2 million in Q4 2024, and down 19.15% on a QoQ basis from $3.3 million in Q3 2025.
Siga Technologies (SIGA) Other Non-Current Liabilities (2011 - 2025) Analysis & Trends
Siga Technologies (SIGA) has 15 years of Other Non-Current Liabilities data on file, last reported at $2.7 million in Q4 2025.
- Quarterly Other Non-Current Liabilities fell 17.1% year-over-year to $2.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.7 million (down 17.1% YoY) and the FY2025 annual result came in at $2.7 million, down 17.1% from the prior year.
- Other Non-Current Liabilities retreated to $2.7 million in Q4 2025, from $3.3 million in the prior quarter.
- In the past five years, Other Non-Current Liabilities ranged from a high of $6.5 million in Q4 2021 to a low of $2.7 million in Q4 2025.
- A 5-year average of $4.0 million and a median of $3.5 million in 2022 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2022 — Other Non-Current Liabilities slumped 48.51% — and 2024, when it advanced 7.93%.
- Tracing SIGA's Other Non-Current Liabilities over 5 years: stood at $6.5 million in 2021, then tumbled by 48.51% to $3.4 million in 2022, then grew by 0.54% to $3.4 million in 2023, then retreated by 5.2% to $3.2 million in 2024, then declined by 17.1% to $2.7 million in 2025.
- The last three Other Non-Current Liabilities figures came in at $2.7 million (Q4 2025), $3.3 million (Q3 2025), and $3.3 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Siga Technologies | 213.74 Mn | 58.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.65 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.30 Mn |
| Mar 31, 2025 | 3.13 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.61 Mn |
| Jun 30, 2024 | 3.72 Mn |
| Mar 31, 2024 | 3.34 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.50 Mn |
| Jun 30, 2023 | 3.45 Mn |
| Mar 31, 2023 | 3.35 Mn |
| Dec 31, 2022 | 3.36 Mn |
| Sep 30, 2022 | 3.63 Mn |
| Jun 30, 2022 | 3.48 Mn |
| Mar 31, 2022 | 6.17 Mn |
| Dec 31, 2021 | 6.52 Mn |
| Sep 30, 2021 | 6.34 Mn |
| Jun 30, 2021 | 5.30 Mn |
| Mar 31, 2021 | 5.72 Mn |